J
ISSUER//CIK 0001640455
Jounce Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A102.8 KBJounce Therapeutics, Inc.Feb 14, 8:50 AM ET·0001172661-24-000930
- SC 13G92.3 KBJounce Therapeutics, Inc.Feb 9, 4:05 PM ET·0001493152-24-005665
- SC 13G/A27.2 KBJounce Therapeutics, Inc.Feb 2, 12:28 PM ET·0001085146-24-000646
- SC 13D/A95.2 KBJounce Therapeutics, Inc.May 5, 4:34 PM ET·0001214659-23-006565
- 8-K567.2 KBJounce Therapeutics, Inc.May 4, 7:22 AM ET·0001640455-23-000093
- 10-K/A6.6 MBJounce Therapeutics, Inc.Apr 28, 2:46 PM ET·0001640455-23-000066
- SC 13G92.3 KBJounce Therapeutics, Inc.Apr 12, 4:15 PM ET·0001493152-23-011994
- SC 13D/A96.5 KBJounce Therapeutics, Inc.Apr 7, 4:00 PM ET·0001214659-23-005107
- 8-K155.8 KBJounce Therapeutics, Inc.Mar 30, 4:08 PM ET·0001640455-23-000045
- SC 13D/A80.0 KBJounce Therapeutics, Inc.Mar 28, 4:00 PM ET·0001214659-23-004299
Insiders
10- CELGENE CORP /DE/10% Owner
- Cole Hugh MChief Business Officer
- Concentra Biosciences, LLC10% Owner
- Diaz LuisDirector
- Drapkin Kimberlee CCFO and Treasurer
- Duncan Barbara GayleDirector
- GILEAD SCIENCES, INC.10% Owner
- Hadley Harbor Master Investors (Cayman) L.P.10% Owner
- Higgons John DuncanDirector
- Iannone RobertDirector
Tickers
No tickers on record
Addresses
business
780 MEMORIAL DRIVE
CAMBRIDGE, MA, 02139
mailing
780 MEMORIAL DRIVE
CAMBRIDGE, MA, 02139